Retatrutide, from Soma Chems , is gaining increasing attention as a innovative therapy for weight management . This innovative drug merges the properties of a GLP-1 receptor stimulant and a GIP receptor stimulant, intended to effectively promote weight loss but also improve related metabolic issues . Early clinical trials have indicated promising r